Binding of anti-inflammatory a-melanocyte-stimulating-hormone peptides and proinflammatory cytokines to receptors on melanoma cells

Krzysztof Lyson, Giuliana Ceriani, Akira Takashima, Anna Catania, James M. Lipton

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

α-Melanocyte-stimulating hormone (α-MSH1-13), a peptide derived from proopiomelanocortin, has remarkable anti-inflammatory and antipyretic activities. This peptide and a tripeptide that forms the COOH-terminal portion of the molecule (α-MSH11-13; Lys Pro Val) inhibit inflammation when given centrally or peripherally. Because of the similarity in their actions, the tripeptide has been presumed to be the amino acid message sequence underlying the effects of α-MSH1-13. To test the possibility that the two peptides occupy the same receptors, competitive binding experiments were performed with B16 mouse melanoma cells that are known to have α-MSH1-13 receptors. In these experiments, α-MSH11-13 did not inhibit binding of a radiolabelled α-MSH1-13 analog. This finding suggests that α-MSH1-13 and α-MSH11-13 exert their anti- inflammatory/antipyretic/anticytokine effects via stimulation of separate receptors. Because α-MSH inhibits the effects of several cytokines including inflammation caused by interleukin (IL)-6 and IL-8, the capacity of these cytokines to compete for α-MSH binding sites was tested. There was no evidence that these proinflammatory cytokines bind to α-MSH receptors on murine melanoma cells. Although further tests with host cells involved in inflammation are required, the latter result is the first evidence that the mechanism of anticytokine action of α-MSH does not depend upon peptide/cytokine competition for binding sites.

Original languageEnglish
Pages (from-to)121-126
Number of pages6
JournalNeuroImmunoModulation
Volume1
Issue number2
DOIs
Publication statusPublished - 1994

Fingerprint

Melanocyte-Stimulating Hormones
Cytokine Receptors
Melanoma
Anti-Inflammatory Agents
Cytokines
Antipyretics
Peptides
Inflammation
Binding Sites
Pro-Opiomelanocortin
Experimental Melanomas
Competitive Binding
Interleukin-8
Amino Acid Sequence
Interleukin-6

Keywords

  • Competitive binding
  • Interleukin-6
  • Interleukin-8
  • Melanocytes
  • Saturation binding
  • α-MSH analog
  • α-MSH<inf>1-13</inf> receptors
  • α-MSH<inf>11-13</inf> receptors

ASJC Scopus subject areas

  • Endocrinology
  • Immunology
  • Endocrine and Autonomic Systems
  • Neurology
  • Neuroscience(all)

Cite this

Binding of anti-inflammatory a-melanocyte-stimulating-hormone peptides and proinflammatory cytokines to receptors on melanoma cells. / Lyson, Krzysztof; Ceriani, Giuliana; Takashima, Akira; Catania, Anna; Lipton, James M.

In: NeuroImmunoModulation, Vol. 1, No. 2, 1994, p. 121-126.

Research output: Contribution to journalArticle

Lyson, Krzysztof ; Ceriani, Giuliana ; Takashima, Akira ; Catania, Anna ; Lipton, James M. / Binding of anti-inflammatory a-melanocyte-stimulating-hormone peptides and proinflammatory cytokines to receptors on melanoma cells. In: NeuroImmunoModulation. 1994 ; Vol. 1, No. 2. pp. 121-126.
@article{7b6f8d09930c473596eba74ea002abde,
title = "Binding of anti-inflammatory a-melanocyte-stimulating-hormone peptides and proinflammatory cytokines to receptors on melanoma cells",
abstract = "α-Melanocyte-stimulating hormone (α-MSH1-13), a peptide derived from proopiomelanocortin, has remarkable anti-inflammatory and antipyretic activities. This peptide and a tripeptide that forms the COOH-terminal portion of the molecule (α-MSH11-13; Lys Pro Val) inhibit inflammation when given centrally or peripherally. Because of the similarity in their actions, the tripeptide has been presumed to be the amino acid message sequence underlying the effects of α-MSH1-13. To test the possibility that the two peptides occupy the same receptors, competitive binding experiments were performed with B16 mouse melanoma cells that are known to have α-MSH1-13 receptors. In these experiments, α-MSH11-13 did not inhibit binding of a radiolabelled α-MSH1-13 analog. This finding suggests that α-MSH1-13 and α-MSH11-13 exert their anti- inflammatory/antipyretic/anticytokine effects via stimulation of separate receptors. Because α-MSH inhibits the effects of several cytokines including inflammation caused by interleukin (IL)-6 and IL-8, the capacity of these cytokines to compete for α-MSH binding sites was tested. There was no evidence that these proinflammatory cytokines bind to α-MSH receptors on murine melanoma cells. Although further tests with host cells involved in inflammation are required, the latter result is the first evidence that the mechanism of anticytokine action of α-MSH does not depend upon peptide/cytokine competition for binding sites.",
keywords = "Competitive binding, Interleukin-6, Interleukin-8, Melanocytes, Saturation binding, α-MSH analog, α-MSH<inf>1-13</inf> receptors, α-MSH<inf>11-13</inf> receptors",
author = "Krzysztof Lyson and Giuliana Ceriani and Akira Takashima and Anna Catania and Lipton, {James M.}",
year = "1994",
doi = "10.1159/000097145",
language = "English",
volume = "1",
pages = "121--126",
journal = "NeuroImmunoModulation",
issn = "1021-7401",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Binding of anti-inflammatory a-melanocyte-stimulating-hormone peptides and proinflammatory cytokines to receptors on melanoma cells

AU - Lyson, Krzysztof

AU - Ceriani, Giuliana

AU - Takashima, Akira

AU - Catania, Anna

AU - Lipton, James M.

PY - 1994

Y1 - 1994

N2 - α-Melanocyte-stimulating hormone (α-MSH1-13), a peptide derived from proopiomelanocortin, has remarkable anti-inflammatory and antipyretic activities. This peptide and a tripeptide that forms the COOH-terminal portion of the molecule (α-MSH11-13; Lys Pro Val) inhibit inflammation when given centrally or peripherally. Because of the similarity in their actions, the tripeptide has been presumed to be the amino acid message sequence underlying the effects of α-MSH1-13. To test the possibility that the two peptides occupy the same receptors, competitive binding experiments were performed with B16 mouse melanoma cells that are known to have α-MSH1-13 receptors. In these experiments, α-MSH11-13 did not inhibit binding of a radiolabelled α-MSH1-13 analog. This finding suggests that α-MSH1-13 and α-MSH11-13 exert their anti- inflammatory/antipyretic/anticytokine effects via stimulation of separate receptors. Because α-MSH inhibits the effects of several cytokines including inflammation caused by interleukin (IL)-6 and IL-8, the capacity of these cytokines to compete for α-MSH binding sites was tested. There was no evidence that these proinflammatory cytokines bind to α-MSH receptors on murine melanoma cells. Although further tests with host cells involved in inflammation are required, the latter result is the first evidence that the mechanism of anticytokine action of α-MSH does not depend upon peptide/cytokine competition for binding sites.

AB - α-Melanocyte-stimulating hormone (α-MSH1-13), a peptide derived from proopiomelanocortin, has remarkable anti-inflammatory and antipyretic activities. This peptide and a tripeptide that forms the COOH-terminal portion of the molecule (α-MSH11-13; Lys Pro Val) inhibit inflammation when given centrally or peripherally. Because of the similarity in their actions, the tripeptide has been presumed to be the amino acid message sequence underlying the effects of α-MSH1-13. To test the possibility that the two peptides occupy the same receptors, competitive binding experiments were performed with B16 mouse melanoma cells that are known to have α-MSH1-13 receptors. In these experiments, α-MSH11-13 did not inhibit binding of a radiolabelled α-MSH1-13 analog. This finding suggests that α-MSH1-13 and α-MSH11-13 exert their anti- inflammatory/antipyretic/anticytokine effects via stimulation of separate receptors. Because α-MSH inhibits the effects of several cytokines including inflammation caused by interleukin (IL)-6 and IL-8, the capacity of these cytokines to compete for α-MSH binding sites was tested. There was no evidence that these proinflammatory cytokines bind to α-MSH receptors on murine melanoma cells. Although further tests with host cells involved in inflammation are required, the latter result is the first evidence that the mechanism of anticytokine action of α-MSH does not depend upon peptide/cytokine competition for binding sites.

KW - Competitive binding

KW - Interleukin-6

KW - Interleukin-8

KW - Melanocytes

KW - Saturation binding

KW - α-MSH analog

KW - α-MSH<inf>1-13</inf> receptors

KW - α-MSH<inf>11-13</inf> receptors

UR - http://www.scopus.com/inward/record.url?scp=0028401899&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028401899&partnerID=8YFLogxK

U2 - 10.1159/000097145

DO - 10.1159/000097145

M3 - Article

C2 - 7489322

AN - SCOPUS:0028401899

VL - 1

SP - 121

EP - 126

JO - NeuroImmunoModulation

JF - NeuroImmunoModulation

SN - 1021-7401

IS - 2

ER -